Oric Pharmaceuticals (ORIC)
(Delayed Data from NSDQ)
$11.90 USD
+0.66 (5.87%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $11.89 -0.01 (-0.08%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.42 |
EPS Last Quarter | -0.37 |
Last EPS Surprise | 15.91% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.68 |
Next Year | -1.89 |
EPS (TTM) | -1.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.42 | -0.43 | -1.68 | -1.89 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.42 | -0.43 | -1.68 | -1.97 |
High Estimate | -0.40 | -0.42 | -1.63 | -1.58 |
Low Estimate | -0.43 | -0.44 | -1.69 | -2.19 |
Year ago EPS | -0.50 | -0.44 | -1.96 | -1.68 |
Year over Year Growth Est. | 16.00% | 2.27% | 14.29% | -12.80% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.42 | -0.43 | -1.68 | -1.89 |
7 Days Ago | -0.42 | -0.43 | -1.68 | -1.89 |
30 Days Ago | -0.42 | -0.43 | -1.68 | -1.89 |
60 Days Ago | -0.42 | -0.43 | -1.68 | -1.89 |
90 Days Ago | -0.43 | -0.44 | -1.75 | -1.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.42 | -0.43 | -1.68 | -1.89 |
Zacks Consensus Estimate | -0.42 | -0.43 | -1.68 | -1.89 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.37 | -0.49 | -0.44 | -0.50 | NA |
Estimate | -0.44 | -0.49 | -0.46 | -0.58 | NA |
Difference | 0.07 | 0.00 | 0.02 | 0.08 | 0.04 |
Surprise | 15.91% | 0.00% | 4.35% | 13.79% | 8.51% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more